|
| ||||||||
J. Biol. Chem., Vol. 276, Issue 32, 29839-29845, August 10,
2001
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
§,
,
,
,
,
,
From the Chemokines coordinate many aspects of leukocyte migration. As
chemoattractants they play an important role in the innate and
acquired immune response. There is good experimental evidence
that N-terminal truncation by secreted or cell surface proteases
is a way of modulating chemokine action. The localization of
CD26/dipeptidyl peptidase IV on cell surfaces and in biological
fluids, its primary specificity, and the type of naturally occurring
truncated chemokines are consistent with such a function.
We determined the steady-state catalytic parameters for a relevant selection
of chemokines (CCL3b, CCL5, CCL11, CCL22, CXCL9, CXCL10, CXCL11, and
CXCL12) previously reported to alter their chemotactic behavior due
to CD26/dipeptidyl peptidase IV-catalyzed truncation. The results
reveal a striking selectivity for stromal cell-derived factor-1
Laboratory of Medical Biochemistry, Department of
Pharmaceutical Sciences, University of Antwerp, Universiteitsplein 1 S6,
B-2610 Antwerp, Belgium, ¶ Laboratory of Molecular Immunology,
Rega Institute for Medical Research, K.U. Leuven, Minderbroedersstraat
10, B-3000 Leuven, Belgium,
Laboratory of Medicinal Chemistry, Department of
Pharmaceutical Sciences, University of Antwerp, Universiteitsplein 1 S4,
B-2610 Antwerp, Belgium
(CXCL12) and
macrophage-derived chemokine (CCL22). The kinetic parameters support
the hypothesis that CD26/dipeptidyl peptidase IV contributes to the
degradation of certain chemokines in vivo. The data not only
provide insight into the selectivity of the enzyme for specific
chemokines, but they also contribute to the general understanding of
CD26/dipeptidyl peptidase IV secondary substrate
specificity.
zonder Onderzoeks Fonds Project from the
University of Antwerp and by Flemish Fund for Scientific Research
grants (to P. P., C. D., G. B., and I. D. M.) and
project G0039.01.The costs of publication of this article were
defrayed in part by the payment of page charges. The article must
therefore be hereby marked "advertisement" in accordance with
18 U.S.C. Section 1734 solely to indicate this
fact.
The amino acid sequence of this protein can be accessed through NCBI
Protein Database under NCBI accession numbers P27487
(DPP IV/CD26), A28815
(RANTES), O00626
(MDC), P16619
(LD78
), P48061
SDF-1
), P51671
(eotaxin), O14625
(I-TAC), P02778
(IP-10), and Q07325
(Mig).
This article has been cited by other articles: (Search Google Scholar for Other Citing Articles)
![]() |
D. REINHOLD, A. BITON, A. GOIHL, S. PIEPER, U. LENDECKEL, J. FAUST, K. NEUBERT, U. BANK, M. TAGER, S. ANSORGE, and S. BROCKE Dual Inhibition of Dipeptidyl Peptidase IV and Aminopeptidase N Suppresses Inflammatory Immune Responses Ann. N.Y. Acad. Sci., September 1, 2007; 1110(1): 402 - 409. [Abstract] [Full Text] [PDF] |
||||
|
| |||||
![]() |
A. L. Ponte, E. Marais, N. Gallay, A. Langonne, B. Delorme, O. Herault, P. Charbord, and J. Domenech The In Vitro Migration Capacity of Human Bone Marrow Mesenchymal Stem Cells: Comparison of Chemokine and Growth Factor Chemotactic Activities Stem Cells, July 1, 2007; 25(7): 1737 - 1745. [Abstract] [Full Text] [PDF] |
||||
|
| |||||
![]() |
P. Proost, A. Mortier, T. Loos, J. Vandercappellen, M. Gouwy, I. Ronsse, E. Schutyser, W. Put, M. Parmentier, S. Struyf, and J. Van Damme Proteolytic processing of CXCL11 by CD13/aminopeptidase N impairs CXCR3 and CXCR7 binding and signaling and reduces lymphocyte and endothelial cell migration Blood, July 1, 2007; 110(1): 37 - 44. [Abstract] [Full Text] [PDF] |
||||
|
| |||||
![]() |
V. Preller, A. Gerber, S. Wrenger, M. Togni, D. Marguet, J. Tadje, U. Lendeckel, C. Rocken, J. Faust, K. Neubert, B. Schraven, R. Martin, S. Ansorge, S. Brocke, and D. Reinhold TGF-beta1-Mediated Control of Central Nervous System Inflammation and Autoimmunity through the Inhibitory Receptor CD26 J. Immunol., April 1, 2007; 178(7): 4632 - 4640. [Abstract] [Full Text] [PDF] |
||||
|
| |||||
![]() |
T. Nakayama, N. Mutsuga, and G. Tosato FGF2 posttranscriptionally down-regulates expression of SDF1 in bone marrow stromal cells through FGFR1 IIIc Blood, February 15, 2007; 109(4): 1363 - 1372. [Abstract] [Full Text] [PDF] |
||||
|
| |||||
![]() |
H.-J. Lee, Y.-S. Chen, C.-Y. Chou, C.-H. Chien, C.-H. Lin, G.-G. Chang, and X. Chen Investigation of the Dimer Interface and Substrate Specificity of Prolyl Dipeptidase DPP8 J. Biol. Chem., December 15, 2006; 281(50): 38653 - 38662. [Abstract] [Full Text] [PDF] |
||||
|
| |||||
![]() |
W. H. Peranteau, M. Endo, O. O. Adibe, A. Merchant, P. W. Zoltick, and A. W. Flake CD26 inhibition enhances allogeneic donor-cell homing and engraftment after in utero hematopoietic-cell transplantation Blood, December 15, 2006; 108(13): 4268 - 4274. [Abstract] [Full Text] [PDF] |
||||
|
| |||||
![]() |
J. Mu, J. Woods, Y.-P. Zhou, R. S. Roy, Z. Li, E. Zycband, Y. Feng, L. Zhu, C. Li, A. D. Howard, David. E. Moller, N. A. Thornberry, and B. B. Zhang Chronic Inhibition of Dipeptidyl Peptidase-4 With a Sitagliptin Analog Preserves Pancreatic {beta}-Cell Mass and Function in a Rodent Model of Type 2 Diabetes Diabetes, June 1, 2006; 55(6): 1695 - 1704. [Abstract] [Full Text] [PDF] |
||||
|
| |||||
![]() |
C. Y. Edosada, C. Quan, C. Wiesmann, T. Tran, D. Sutherlin, M. Reynolds, J. M. Elliott, H. Raab, W. Fairbrother, and B. B. Wolf Selective Inhibition of Fibroblast Activation Protein Protease Based on Dipeptide Substrate Specificity J. Biol. Chem., March 17, 2006; 281(11): 7437 - 7444. [Abstract] [Full Text] [PDF] |
||||
|
| |||||
![]() |
K. Ottersbach, J. Mclean, N. W. Isaacs, and G. J. Graham A310 helical turn is essential for the proliferation-inhibiting properties of macrophage inflammatory protein-1 alpha (CCL3) Blood, February 15, 2006; 107(4): 1284 - 1291. [Abstract] [Full Text] [PDF] |
||||
|
| |||||
![]() |
M. G. Narducci, E. Scala, A. Bresin, E. Caprini, M. C. Picchio, D. Remotti, G. Ragone, F. Nasorri, M. Frontani, D. Arcelli, S. Volinia, G. A. Lombardo, G. Baliva, M. Napolitano, and G. Russo Skin homing of Sezary cells involves SDF-1-CXCR4 signaling and down-regulation of CD26/dipeptidylpeptidase IV Blood, February 1, 2006; 107(3): 1108 - 1115. [Abstract] [Full Text] [PDF] |
||||
|
| |||||
![]() |
T. Lapidot, A. Dar, and O. Kollet How do stem cells find their way home? Blood, September 15, 2005; 106(6): 1901 - 1910. [Abstract] [Full Text] [PDF] |
||||
|
| |||||
![]() |
Y. Guo, G. Hangoc, H. Bian, L. M. Pelus, and H. E. Broxmeyer SDF-1/CXCL12 Enhances Survival and Chemotaxis of Murine Embryonic Stem Cells and Production of Primitive and Definitive Hematopoietic Progenitor Cells Stem Cells, September 1, 2005; 23(9): 1324 - 1332. [Abstract] [Full Text] [PDF] |
||||
|
| |||||
![]() |
D. A. Davis, K. E. Singer, M. De La Luz Sierra, M. Narazaki, F. Yang, H. M. Fales, R. Yarchoan, and G. Tosato Identification of carboxypeptidase N as an enzyme responsible for C-terminal cleavage of stromal cell-derived factor-1{alpha} in the circulation Blood, June 15, 2005; 105(12): 4561 - 4568. [Abstract] [Full Text] [PDF] |
||||
|
| |||||
![]() |
K. Aertgeerts, I. Levin, L. Shi, G. P. Snell, A. Jennings, G. S. Prasad, Y. Zhang, M. L. Kraus, S. Salakian, V. Sridhar, R. Wijnands, and M. G. Tennant Structural and Kinetic Analysis of the Substrate Specificity of Human Fibroblast Activation Protein {alpha} J. Biol. Chem., May 20, 2005; 280(20): 19441 - 19444. [Abstract] [Full Text] [PDF] |
||||
|
| |||||
![]() |
C.-H. Chien, L.-H. Huang, C.-Y. Chou, Y.-S. Chen, Y.-S. Han, G.-G. Chang, P.-H. Liang, and X. Chen One Site Mutation Disrupts Dimer Formation in Human DPP-IV Proteins J. Biol. Chem., December 10, 2004; 279(50): 52338 - 52345. [Abstract] [Full Text] [PDF] |
||||
|
| |||||
![]() |
R. Sadir, A. Imberty, F. Baleux, and H. Lortat-Jacob Heparan Sulfate/Heparin Oligosaccharides Protect Stromal Cell-derived Factor-1 (SDF-1)/CXCL12 against Proteolysis Induced by CD26/Dipeptidyl Peptidase IV J. Biol. Chem., October 15, 2004; 279(42): 43854 - 43860. [Abstract] [Full Text] [PDF] |
||||
|
| |||||
![]() |
U. Forssmann, I. Hartung, R. Balder, B. Fuchs, S. E. Escher, N. Spodsberg, Y. Dulkys, M. Walden, A. Heitland, A. Braun, W.-G. Forssmann, and J. Elsner n-Nonanoyl-CC Chemokine Ligand 14, a Potent CC Chemokine Ligand 14 Analogue That Prevents the Recruitment of Eosinophils in Allergic Airway Inflammation J. Immunol., September 1, 2004; 173(5): 3456 - 3466. [Abstract] [Full Text] [PDF] |
||||
|
| |||||
![]() |
H. M. S. Algood, P. L. Lin, D. Yankura, A. Jones, J. Chan, and J. L. Flynn TNF Influences Chemokine Expression of Macrophages In Vitro and That of CD11b+ Cells In Vivo during Mycobacterium tuberculosis Infection J. Immunol., June 1, 2004; 172(11): 6846 - 6857. [Abstract] [Full Text] [PDF] |
||||
|
| |||||
![]() |
P. Proost, S. Verpoest, K. V. de Borne, E. Schutyser, S. Struyf, W. Put, I. Ronsse, B. Grillet, G. Opdenakker, and J. V. Damme Synergistic induction of CXCL9 and CXCL11 by Toll-like receptor ligands and interferon-{gamma} in fibroblasts correlates with elevated levels of CXCR3 ligands in septic arthritis synovial fluids J. Leukoc. Biol., May 1, 2004; 75(5): 777 - 784. [Abstract] [Full Text] [PDF] |
||||
|
| |||||
![]() |
P. J. Hensbergen, D. Verzijl, C. I. A. Balog, R. Dijkman, R. C. van der Schors, E. M. H. van der Raaij-Helmer, M. J. A. van der Plas, R. Leurs, A. M. Deelder, M. J. Smit, and C. P. Tensen Furin Is a Chemokine-modifying Enzyme: IN VITRO AND IN VIVO PROCESSING OF CXCL10 GENERATES A C-TERMINALLY TRUNCATED CHEMOKINE RETAINING FULL ACTIVITY J. Biol. Chem., April 2, 2004; 279(14): 13402 - 13411. [Abstract] [Full Text] [PDF] |
||||
|
| |||||
![]() |
M. De La Luz Sierra, F. Yang, M. Narazaki, O. Salvucci, D. Davis, R. Yarchoan, H. H. Zhang, H. Fales, and G. Tosato Differential processing of stromal-derived factor-1{alpha} and stromal-derived factor-1{beta} explains functional diversity Blood, April 1, 2004; 103(7): 2452 - 2459. [Abstract] [Full Text] [PDF] |
||||
|
| |||||
![]() |
K. Aertgeerts, S. Ye, M. G. Tennant, M. L. Kraus, J. Rogers, B.-C. Sang, R. J. Skene, D. R. Webb, and G. S. Prasad Crystal structure of human dipeptidyl peptidase IV in complex with a decapeptide reveals details on substrate specificity and tetrahedral intermediate formation Protein Sci., February 1, 2004; 13(2): 412 - 421. [Abstract] [Full Text] [PDF] |
||||
|
| |||||
![]() |
L. V. Beerepoot, N. Mehra, J. S. P. Vermaat, B. A. Zonnenberg, M. F. G. B. Gebbink, and E. E. Voest Increased levels of viable circulating endothelial cells are an indicator of progressive disease in cancer patients Ann. Onc., January 1, 2004; 15(1): 139 - 145. [Abstract] [Full Text] [PDF] |
||||
|
| |||||
![]() |
S. Villalba, O. Salvucci, Y. Aoki, M. D. L. L. Sierra, G. Gupta, D. Davis, K. Wyvill, R. Little, R. Yarchoan, and G. Tosato Serum inactivation contributes to the failure of stromal-derived factor-1 to block HIV-I infection in vivo J. Leukoc. Biol., November 1, 2003; 74(5): 880 - 888. [Abstract] [Full Text] [PDF] |
||||
|
| |||||
![]() |
M. J. James, L. Belaramani, K. Prodromidou, A. Datta, S. Nourshargh, G. Lombardi, J. Dyson, D. Scott, E. Simpson, L. Cardozo, A. Warrens, R. M. Szydlo, R. I. Lechler, and F. M. Marelli-Berg Anergic T cells exert antigen-independent inhibition of cell-cell interactions via chemokine metabolism Blood, September 15, 2003; 102(6): 2173 - 2179. [Abstract] [Full Text] [PDF] |
||||
|
| |||||
![]() |
H.-C. Cheng, M. Abdel-Ghany, and B. U. Pauli A Novel Consensus Motif in Fibronectin Mediates Dipeptidyl Peptidase IV Adhesion and Metastasis J. Biol. Chem., June 27, 2003; 278(27): 24600 - 24607. [Abstract] [Full Text] [PDF] |
||||
|
| |||||
![]() |
K. W. Christopherson II, S. Cooper, and H. E. Broxmeyer Cell surface peptidase CD26/DPPIV mediates G-CSF mobilization of mouse progenitor cells Blood, June 15, 2003; 101(12): 4680 - 4686. [Abstract] [Full Text] [PDF] |
||||
|
| |||||
![]() |
L. Zhu, C. Tamvakopoulos, D. Xie, J. Dragovic, X. Shen, J. E. Fenyk-Melody, K. Schmidt, A. Bagchi, P. R. Griffin, N. A. Thornberry, and R. Sinha Roy The Role of Dipeptidyl Peptidase IV in the Cleavage of Glucagon Family Peptides: IN VIVO METABOLISM OF PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE-(1-38) J. Biol. Chem., June 13, 2003; 278(25): 22418 - 22423. [Abstract] [Full Text] [PDF] |
||||
|
| |||||
![]() |
K. W. Christopherson II, G. Hangoc, and H. E. Broxmeyer Cell Surface Peptidase CD26/Dipeptidylpeptidase IV Regulates CXCL12/Stromal Cell-Derived Factor-1{alpha}-Mediated Chemotaxis of Human Cord Blood CD34+ Progenitor Cells J. Immunol., December 15, 2002; 169(12): 7000 - 7008. [Abstract] [Full Text] [PDF] |
||||
|
| |||||
![]() |
I. Szabo, X.-H. Chen, L. Xin, M. W. Adler, O. M. Z. Howard, J. J. Oppenheim, and T. J. Rogers Heterologous desensitization of opioid receptors by chemokines inhibits chemotaxis and enhances the perception of pain PNAS, August 6, 2002; 99(16): 10276 - 10281. [Abstract] [Full Text] [PDF] |
||||
|
| |||||
![]() |
G. Ghersi, H. Dong, L. A. Goldstein, Y. Yeh, L. Hakkinen, H. S. Larjava, and W.-T. Chen Regulation of Fibroblast Migration on Collagenous Matrix by a Cell Surface Peptidase Complex J. Biol. Chem., August 2, 2002; 277(32): 29231 - 29241. [Abstract] [Full Text] [PDF] |
||||
|
| |||||
![]() |
P. Proost, E. Schutyser, P. Menten, S. Struyf, A. Wuyts, G. Opdenakker, M. Detheux, M. Parmentier, C. Durinx, A.-M. Lambeir, J. Neyts, S. Liekens, P. C. Maudgal, A. Billiau, and J. Van Damme Amino-terminal truncation of CXCR3 agonists impairs receptor signaling and lymphocyte chemotaxis, while preserving antiangiogenic properties Blood, December 15, 2001; 98(13): 3554 - 3561. [Abstract] [Full Text] [PDF] |
||||
|
| |||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | SEARCH RESULT |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |